Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling.

Dole NS, Mazur CM, Acevedo C, Lopez JP, Monteiro DA, Fowler TW, Gludovatz B, Walsh F, Regan JN, Messina S, Evans DS, Lang TF, Zhang B, Ritchie RO, Mohammad KS, Alliston T.

Cell Rep. 2017 Nov 28;21(9):2585-2596. doi: 10.1016/j.celrep.2017.10.115.

2.

Parallel mechanisms suppress cochlear bone remodeling to protect hearing.

Jáuregui EJ, Akil O, Acevedo C, Hall-Glenn F, Tsai BS, Bale HA, Liebenberg E, Humphrey MB, Ritchie RO, Lustig LR, Alliston T.

Bone. 2016 Aug;89:7-15. doi: 10.1016/j.bone.2016.04.010. Epub 2016 Apr 13.

3.

Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis.

Fowler TW, Acevedo C, Mazur CM, Hall-Glenn F, Fields AJ, Bale HA, Ritchie RO, Lotz JC, Vail TP, Alliston T.

Sci Rep. 2017 Mar 22;7:44618. doi: 10.1038/srep44618.

4.

Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone.

Rolvien T, Krause M, Jeschke A, Yorgan T, Püschel K, Schinke T, Busse B, Demay MB, Amling M.

Bone. 2017 Oct;103:78-87. doi: 10.1016/j.bone.2017.06.022. Epub 2017 Jun 27.

PMID:
28666969
5.

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.

Notsu M, Kanazawa I, Takeno A, Yokomoto-Umakoshi M, Tanaka KI, Yamaguchi T, Sugimoto T.

Calcif Tissue Int. 2017 Apr;100(4):402-411. doi: 10.1007/s00223-017-0243-x. Epub 2017 Feb 22.

PMID:
28229177
6.

Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling.

Alemi AS, Mazur CM, Fowler TW, Woo JJ, Knott PD, Alliston T.

Bone Rep. 2018 Oct 3;9:145-153. doi: 10.1016/j.bonr.2018.09.004. eCollection 2018 Dec.

7.

Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.

Tokarz D, Martins JS, Petit ET, Lin CP, Demay MB, Liu ES.

J Bone Miner Res. 2018 Mar;33(3):499-509. doi: 10.1002/jbmr.3327. Epub 2017 Nov 17.

8.

Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.

Tang SY, Herber RP, Ho SP, Alliston T.

J Bone Miner Res. 2012 Sep;27(9):1936-50. doi: 10.1002/jbmr.1646.

9.

Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.

Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jähn K, Kato S, Wysolmerski J, Bonewald LF.

J Bone Miner Res. 2012 May;27(5):1018-29. doi: 10.1002/jbmr.1567.

10.

The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Chen H, Senda T, Kubo KY.

Med Mol Morphol. 2015 Jun;48(2):61-8. doi: 10.1007/s00795-015-0099-y. Epub 2015 Mar 20. Review.

PMID:
25791218
11.

Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.

Kao RS, Abbott MJ, Louie A, O'Carroll D, Lu W, Nissenson R.

Bone. 2013 Aug;55(2):277-87. doi: 10.1016/j.bone.2013.04.001. Epub 2013 Apr 10.

12.

MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts.

Zeng HC, Bae Y, Dawson BC, Chen Y, Bertin T, Munivez E, Campeau PM, Tao J, Chen R, Lee BH.

Nat Commun. 2017 Apr 11;8:15000. doi: 10.1038/ncomms15000.

13.

In vitro and in vivo study on osteocyte-specific mechanical signaling pathways.

Yang W, Kalajzic I, Lu Y, Guo D, Harris MA, Gluhak-Heinrich J, Bonewald LF, Feng JQ, Rowe DW, Harris SE.

J Musculoskelet Neuronal Interact. 2004 Dec;4(4):386-7. No abstract available.

14.

Osteoblastic responses to TGF-beta during bone remodeling.

Erlebacher A, Filvaroff EH, Ye JQ, Derynck R.

Mol Biol Cell. 1998 Jul;9(7):1903-18.

15.

Osteocyte-driven bone remodeling.

Bellido T.

Calcif Tissue Int. 2014 Jan;94(1):25-34. doi: 10.1007/s00223-013-9774-y. Epub 2013 Sep 4. Review.

16.

Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis.

Ormsby RT, Cantley M, Kogawa M, Solomon LB, Haynes DR, Findlay DM, Atkins GJ.

Acta Biomater. 2016 Mar;33:242-51. doi: 10.1016/j.actbio.2016.01.016. Epub 2016 Jan 18.

PMID:
26796208
17.

Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.

Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, Dedic C, Maeda A, Lotinun S, Baron R, Pajevic PD.

J Biol Chem. 2013 Jul 12;288(28):20122-34. doi: 10.1074/jbc.M112.441360. Epub 2013 Jun 2.

18.

Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis.

Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaissé JM, Foged NT.

J Biol Chem. 2002 Nov 15;277(46):44061-7. Epub 2002 Sep 10.

19.

The amazing osteocyte.

Bonewald LF.

J Bone Miner Res. 2011 Feb;26(2):229-38. doi: 10.1002/jbmr.320. Review.

20.

[Bone and Calcium Research Update 2015. Regulation of bone remodeling by osteocytes].

Nakashima T.

Clin Calcium. 2015 Jan;25(1):21-8. doi: CliCa15012128. Review. Japanese.

PMID:
25530519

Supplemental Content

Support Center